EMD Serono

Features in Backgrounds of Microscopy Images Introduce Biases in Machine Learning Analyses (2024) Greenblott DN, Johann F, Snell JR, Gieseler H, Calderon CP, Randolph TW Journal article Disease stability over 5 years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication (2022) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Dangond F, Jack D, Vermersch P Journal article Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies (2021) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Dangond F, Keller B, Jack D, Vermersch P Journal article BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid (2020) Eslami M, Meinl E, Eibel H, Willen L, Donzé O, Distl O, Schneider H, et al. Journal article A Phase IIb, Randomized, Double-blind Study in Patients with Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared with Placebo in Patients with an Inadequate Response to Methotrexate (2020) Peterfy C, Buch M, Choy E, Schett G, Parsons-Rich D, Patel A, Zima Y, et al. Conference contribution Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies (2019) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Vermersch P, Dangond F, Keller B, Jack D Conference contribution Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study (2019) Giovannoni G, Sorensen PS, Cook S, Rammohan KW, Rieckmann P, Comi G, Dangond F, et al. Journal article Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis (2019) Comi G, Cook S, Giovannoni G, Rieckmann P, Sorensen PS, Vermersch P, Galazka A, et al. Journal article Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis (2019) Vermersch P, Martinelli V, Pfleger C, Rieckmann P, Alonso-Magdalena L, Galazka A, Dangond F, Phillips L Journal article STRUCTURAL EFFECTS OF INTRA-ARTICULAR SPRIFERMIN IN SYMPTOMATIC RADIOGRAPHIC KNEE OSTEOARTHRITIS: A POST-HOC ANALYSIS OF CARTILAGE AND NON-CARTILAGINOUS TISSUE ALTERATIONS OF THE 2-YEAR DATA FROM A 5-YEAR RANDOMISED, PLACEBO-CONTROLLED, PHASE II STUDY (2018) Roemer F, Kraines J, Aydemir A, Wax S, Crema M, Hochberg M, Guermazi A Conference contribution